DR
Donald Richards
math.STstat.THmath.PRstat.APBreast cancercancerAdenocarcinomaAntineoplastic AgentsAntineoplastic Combined Chemotherapy Protocolsclinical trial
On Valency
published · living versionsW_xfwfb82t·v1 · currentpublished
The affinely invariant distance correlation
with Johannes Dueck, Dominic Edelmann, Tilmann Gneiting
1 version
Preprints & journals
103 papers in the corpus · 1980–2026Enhanced structural reverse remodeling following LVAD support in patients with TTN truncating variants.42927226 · Richards, Donald, Cole, Robert M, Kittleson, Michelle et al.2026 · 0 citationsJHLT open. 2026;14:100688
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial.41349554 · Javle, Milind, Fountzilas, Christos, Liao, Chih-Yi et al.2026 · 12 citationsThe lancet. Gastroenterology & hepatology. 2026;11(2):137-149
Hyperdeterminantal Total Positivity2412.03000v2 · Kenneth W. Johnson, Donald St. P. Richards2024 · 0 citationsSIGMA 21 (2025), 055, 18 pages
An explicit Wishart moment formula for the product of two disjoint principal minors2409.14512v1 · Christian Genest, Fr'ed'eric Ouimet, Donald Richards2024 · 4 citationsProceedings of the American Mathematical Society (2025), 153 (3), 1299-1311
Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.38777648 · Lee, Chung-Han, Yogesh Shah, Amishi, Rao, Arpit et al.2025 · 6 citationsEuropean urology. 2024;86(5):470-473
A multicenter, randomized phase 2 study to establish combinations of CBP501, cisplatin and nivolumab for ≥3rd-line treatment of patients with advanced pancreatic adenocarcinoma.38422585 · Enzler, T, Nguyen, A, Misleh, J et al.2024 · 6 citationsEuropean journal of cancer (Oxford, England : 1990). 2024;201:113950
Complete Asymptotic Expansions for the Normalizing Constants of High-Dimensional Matrix Bingham and Matrix Langevin Distributions2402.08663v3 · Armine Bagyan, Donald Richards2024 · 0 citationsSIGMA 20 (2024), 094, 22 pages
Performance of a Cell-Free DNA-Based Multi-cancer Detection Test in Individuals Presenting With Symptoms Suspicious for Cancers.37467458 · Bryce, Alan H, Thiel, David D, Seiden, Michael V et al.2023 · 15 citationsJCO precision oncology. 2023;7:e2200679
Complete Asymptotic Expansions and the High-Dimensional Bingham Distributions2303.10290v2 · Armine Bagyan, Donald Richards2023 · 0 citationsarXiv
Non-Steepness and Maximum Likelihood Estimation Properties of the Truncated Multivariate Normal Distributions2303.10287v3 · Michael Levine, Donald Richards, Jianxi Su2023 · 1 citationarXiv
MRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy.36842467 · He, Kai, Berz, David, Gadgeel, Shirish M et al.2023 · 38 citationsJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2023;18(7):907-921
Hemodynamic Gain Index and Exercise Capacity in Heart Failure With Preserved Ejection Fraction.36543076 · Morales-Oyarvide, Vicente, Richards, Donald, Hendren, Nicholas S et al.2023 · 10 citationsThe American journal of cardiology. 2023;190:17-24
A Basic Treatment of the Distance Covariance2206.10135v1 · Dominic Edelmann, Tobias Terzer, Donald Richards2022 · 2 citationsSankhya, Series B, 83 (2021), S12-S25
A Continuous-Time Markov Chain Model for the Spread of COVID-192206.10179v1 · Armine Bagyan, Donald Richards2022 · 2 citationsarXiv
Product Inequalities for Multivariate Gaussian, Gamma, and Positively Upper Orthant Dependent Distributions2204.06220v2 · Dominic Edelmann, Donald Richards, Thomas Royen2022 · 18 citationsarXiv
Trilaciclib Prior to Chemotherapy in Patients with Metastatic Triple-Negative Breast Cancer: Final Efficacy and Subgroup Analysis from a Randomized Phase II Study.34887261 · Tan, Antoinette R, Wright, Gail S, Thummala, Anu R et al.2022 · 42 citationsClinical cancer research : an official journal of the American Association for Cancer Research. 2022;28(4):629-636
Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies.34408488 · Hussein, Maen, Maglakelidze, Marina, Richards, Donald A et al.2022 · 25 citationsCancer management and research. 2021;13:6207-6218
Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set.34176681 · Klein, E A, Richards, D, Cohn, A et al.2021 · 1,000 citationsAnnals of oncology : official journal of the European Society for Medical Oncology. 2021;32(9):1167-1177
A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer.33786412 · Muscarella, Peter, Bekaii-Saab, Tanios, McIntyre, Kristi et al.2021 · 24 citationsJournal of pancreatic cancer. 2021;7(1):8-19
Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer.33513026 · Bardia, Aditya, Kaklamani, Virginia, Wilks, Sharon et al.2021 · 105 citationsJournal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021;39(12):1360-1370
Efficacy and safety of ofatumumab and bendamustine followed by ofatumumab maintenance in patients with relapsed indolent non-Hodgkin lymphoma after prior rituximab.33448893 · Lyons, Roger M, Shtivelband, Mikhail, Kingsley, Edwin et al.2021 · 2 citationsLeukemia & lymphoma. 2021;62(6):1353-1360
Correction to: Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.33108585 · Ramanathan, Ramesh K, Von Hoff, Daniel D, Eskens, Ferry et al.2020 · 1 citationTargeted oncology. 2020;15(6):803
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma.33215270 · Murray Stewart, Tracy, Von Hoff, Daniel, Fitzgerald, Michael et al.2021 · 18 citationsCancer chemotherapy and pharmacology. 2021;87(1):135-144
Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer.32803633 · Diamond, Jennifer R, Becerra, Carlos, Richards, Donald et al.2021 · 153 citationsBreast cancer research and treatment. 2020;184(1):53-62
Randomised phase II trial of gemcitabine and nab-paclitaxel with necuparanib or placebo in untreated metastatic pancreas ductal adenocarcinoma.32361265 · O'Reilly, Eileen M, Barone, Diletta, Mahalingam, Devalingam et al.2020 · 33 citationsEuropean journal of cancer (Oxford, England : 1990). 2020;132:112-121
Phase Ib Trial of the PI3K Inhibitor Copanlisib Combined with the Allosteric MEK Inhibitor Refametinib in Patients with Advanced Cancer.32314268 · Ramanathan, Ramesh K, Von Hoff, Daniel D, Eskens, Ferry et al.2020 · 52 citationsTargeted oncology. 2020;15(2):163-174
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial.31504118 · Weiss, J M, Csoszi, T, Maglakelidze, M et al.2020 · 167 citationsAnnals of oncology : official journal of the European Society for Medical Oncology. 2019;30(10):1613-1621
Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial.31575503 · Tan, Antoinette R, Wright, Gail S, Thummala, Anu R et al.2020 · 117 citationsThe Lancet. Oncology. 2019;20(11):1587-1601
Independence Properties of the Truncated Multivariate Elliptical Distributions1904.06412v2 · Michael Levine, Donald Richards, Jianxi Su2019 · 1 citationarXiv
Integral Transform Methods in Goodness-of-Fit Testing, II: The Wishart Distributions1903.02653v1 · Elena Hadjicosta, Donald Richards2019 · 8 citationsarXiv
Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study.31160171 · Yardley, Denise A, Hart, Lowell, Favret, Anne et al.2020 · 16 citationsClinical breast cancer. 2019;19(4):268-277.e1
Dependence Properties of B-Spline Copulas1902.04749v1 · Xiaoling Dou, Satoshi Kuriki, Gwo Dong Lin et al.2019 · 4 citationsarXiv
Integral Transform Methods in Goodness-of-Fit Testing, I: The Gamma Distributions1810.07138v1 · Elena Hadjicosta, Donald Richards2018 · 10 citationsarXiv
LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial.30051975 · Golan, Talia, Geva, Ravit, Richards, Donald et al.2019 · 109 citationsJournal of cachexia, sarcopenia and muscle. 2018;9(5):871-879
Loading Monotonicity of Weighted Premiums, and Total Positivity Properties of Weight Functions1806.07957v2 · Donald Richards, Caroline Uhler2018 · 2 citationsarXiv
Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer.29882016 · Rodon, Jordi, Pérez-Fidalgo, Alejandro, Krop, Ian E et al.2019 · 53 citationsCancer chemotherapy and pharmacology. 2018;82(2):285-298
Phase II Study of Taselisib (GDC-0032) in Combination with Fulvestrant in Patients with HER2-Negative, Hormone Receptor-Positive Advanced Breast Cancer.29793946 · Dickler, Maura N, Saura, Cristina, Richards, Donald A et al.2019 · 82 citationsClinical cancer research : an official journal of the American Association for Cancer Research. 2018;24(18):4380-4387
Long-Term Implications of the Revenue Transfer Methodology in the Affordable Care Act1803.01223v3 · Ishan Muzumdar, Donald Richards2018 · 0 citationsarXiv
Whole blood FPR1 mRNA expression predicts both non-small cell and small cell lung cancer.29313979 · Morris, Scott, Vachani, Anil, Pass, Harvey I et al.2018 · 18 citationsInternational journal of cancer. 2018;142(11):2355-2362
Generalized Fréchet Bounds for Cell Entries in Multidimensional Contingency Tables1708.02708v2 · Caroline Uhler, Donald Richards2017 · 0 citationsarXiv
The Distance Standard Deviation1705.05777v2 · Dominic Edelmann, Donald Richards, Daniel Vogel2017 · 20 citationsarXiv
Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients.28289865 · Mahadevan, D, Mita, Monica, Richards, Donald et al.2017 · 5 citationsCancer chemotherapy and pharmacology. 2017;79(4):681-688
Statistical Implications of the Revenue Transfer Methodology in the Affordable Care Act1703.01002v3 · Michelle Li, Donald Richards2017 · 1 citationarXiv
A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients.28202004 · Laquente, Berta, Lopez-Martin, Jose, Richards, Donald et al.2017 · 77 citationsBMC cancer. 2017;17(1):137
Safety, Tolerability, and Preliminary Activity of LB-100, an Inhibitor of Protein Phosphatase 2A, in Patients with Relapsed Solid Tumors: An Open-Label, Dose Escalation, First-in-Human, Phase I Trial.28039265 · Chung, Vincent, Mansfield, Aaron S, Braiteh, Fadi et al.2018 · 128 citationsClinical cancer research : an official journal of the American Association for Cancer Research. 2017;23(13):3277-3284
PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer.27639678 · Yu, Hui, Batenchuk, Cory, Badzio, Andrzej et al.2017 · 135 citationsJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2017;12(1):110-120
Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer.27350064 · Scagliotti, Giorgio, Kang, Jin Hyoung, Smith, David et al.2017 · 70 citationsInvestigational new drugs. 2016;34(5):625-35
A phase II trial of trabectedin in triple-negative and HER2-overexpressing metastatic breast cancer.26749361 · Blum, Joanne L, Gonçalves, Anthony, Efrat, Noa et al.2016 · 19 citationsBreast cancer research and treatment. 2016;155(2):295-302
Phase I Study of CHK1 Inhibitor LY2603618 in Combination with Gemcitabine in Patients with Solid Tumors.27598338 · Calvo, Emiliano, Braiteh, Fadi, Von Hoff, Daniel et al.2017 · 44 citationsOncology. 2016;91(5):251-260
Chi-Square Mixture Representations for the Distribution of the Scalar Schur Complement in a Noncentral Wishart Matrix1512.08159v1 · Constantin Siriteanu, Satoshi Kuriki, Donald Richards et al.2015 · 8 citationsStatistics and Probability Letters 115 (2016) 79-87
Career total: 341 works. 103 are in this corpus.Showing the 50 most recent.
Profile built from the corpus for this byline.
Author records are still filling in while the Hub is in alpha. If this is your page, you'll be able to claim it soon. Spot a mistake? Tell us.